655 (Glyburide and Metformin Hydrochloride 5 mg / 500 mg)
Pill with imprint 655 is Yellow, Capsule-shape and has been identified as Glyburide and metformin hydrochloride 5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 655
Glyburide and metformin hydrochloride
- Imprint:
- 655
- Strength:
- 5 mg / 500 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cadila Healthcare Limited
- National Drug Code (NDC):
- 65841-0826
More about glyburide/metformin
- Glyburide/metformin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Consumer resources
Other brands: Glucovance
Professional resources
- Glyburide and Metformin (FDA)
- Glyburide and Metformin Tablets (FDA)
- Glyburide and Metformin (Wolters Kluwer)
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
